Avanos Medical is a medical devices business based in the US. Avanos Medical shares (AVNS) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $17.87 – a decrease of 6.68% over the previous week. Avanos Medical employs 3,771 staff and has a trailing 12-month revenue of around $681.5 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $17.87 |
|---|---|
| 52-week range | $17.39 - $25.36 |
| 50-day moving average | $22.50 |
| 200-day moving average | $20.88 |
| Wall St. target price | $22.50 |
| PE ratio | 41.6304 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.46 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $17.8 from 2024-11-19
| 1 week (2024-11-14) | -7.05% |
|---|---|
| 1 month (2024-10-21) | -22.17% |
| 3 months (2024-08-21) | -23.31% |
| 6 months (2024-05-21) | -12.27% |
| 1 year (2023-11-21) | -16.00% |
|---|---|
| 2 years (2022-11-21) | -33.41% |
| 3 years (2021-11-19) | 32.47 |
| 5 years (2019-11-21) | 33.99 |
Valuing Avanos Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avanos Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avanos Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, Avanos Medical shares trade at around 42x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Avanos Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $102.2 million.
The EBITDA is a measure of a Avanos Medical's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $681.5 million |
|---|---|
| Operating margin TTM | 9.68% |
| Gross profit TTM | $450 million |
| Return on assets TTM | 2.08% |
| Return on equity TTM | 1.77% |
| Profit margin | 2.3% |
| Book value | $26.73 |
| Market Capitalization | $895.7 million |
TTM: trailing 12 months
We're not expecting Avanos Medical to pay a dividend over the next 12 months.
Over the last 12 months, Avanos Medical's shares have ranged in value from as little as $17.39 up to $25.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Avanos Medical's is 0.925. This would suggest that Avanos Medical's shares are less volatile than average (for this exchange).
Avanos Medical, Inc. , a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.